The Benefits of Hemp Protein Supplementation During Resistance Training
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02529917 |
Recruitment Status :
Completed
First Posted : August 20, 2015
Last Update Posted : May 5, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Sarcopenia | Dietary Supplement: Hemp powder Dietary Supplement: Soy Powder | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 34 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor) |
Primary Purpose: | Other |
Official Title: | The Benefits of Hemp Protein Supplementation During Resistance Training |
Study Start Date : | August 2015 |
Actual Primary Completion Date : | December 2015 |
Actual Study Completion Date : | December 2015 |
Arm | Intervention/treatment |
---|---|
Experimental: Hemp powder
Hemp powder supplement
|
Dietary Supplement: Hemp powder
Hemp powder supplement |
Active Comparator: Soy powder
Soy powder supplement
|
Dietary Supplement: Soy Powder
Soy powder supplement |
- Change in lean tissue mass (kg) [ Time Frame: 8 weeks ]Lean tissue mass measured with dual energy x-ray absrorptiometry
- Change in fat mass (kg) [ Time Frame: 8 weeks ]Fat mass as measured by dual energy x-ray absorptiometry
- Change in bone mass (grams) [ Time Frame: 8 weeks ]Bone mass as measured by dual energy x-ray absorptiometry
- Change in elbow flexor muscle thickness (cm) [ Time Frame: 8 weeks ]Muscle thickness as assessed by ultrasound
- Change in knee extensor muscle thickness (cm) [ Time Frame: 8 weeks ]muscle thickness as measured by ultrasound
- Change in bench press strength (kg) [ Time Frame: 8 weeks ]Bench press strength as assess on a plate-loaded machine by the 1-RM method
- Change in arm curl strength (kg) [ Time Frame: 8 weeks ]Arm curl strength as assessed with dumbbells by the 1-RM method
- Change in leg press strength (kg) [ Time Frame: 8 weeks ]Leg press strength as assessed on a leg-press machine by the 1-RM method
- Change in inflammation by interleukin-6 (mmol/l) levels [ Time Frame: 8 weeks ]Interleukin-6 levels measured from saliva samples
- Change in inflammation by C-reactive protein (mmol/l) levels [ Time Frame: 8 weeks ]C-reactive protein levels measured from saliva samples
- Change in bone resorption (N-telopeptides) (mmol/l) [ Time Frame: 8 weeks ]N-telopeptides measured from urine samples
- Change in voluntary muscle activation (Nm) [ Time Frame: 8 weeks ]Voluntary muscle activation as measured by the interpolated twitch technique

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 45 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- At least 6 months experience with resistance training
Exclusion Criteria:
- Allergies to hemp or soy
- Consumption of other nutritional supplements in previous month
- Answered "yes" to questions on the Physical Activity Readiness Questionnaire

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02529917
Canada, Saskatchewan | |
University of Saskatchewan | |
Saskatoon, Saskatchewan, Canada, S7N 5B2 |
Principal Investigator: | Philip Chilibeck | University of Saskatchewan |
Responsible Party: | Phil Chilibeck, Ph.D., University of Saskatchewan |
ClinicalTrials.gov Identifier: | NCT02529917 |
Other Study ID Numbers: |
15-95 |
First Posted: | August 20, 2015 Key Record Dates |
Last Update Posted: | May 5, 2017 |
Last Verified: | May 2017 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Sarcopenia Muscular Atrophy Neuromuscular Manifestations Neurologic Manifestations |
Nervous System Diseases Atrophy Pathological Conditions, Anatomical |